Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered whole tumor cell-targeted immunotherapy alone or in combination with checkpoint inhibition.

被引：0

作者：

Williams, William

Dakhil, Shaker R.

Calfa, Carmen Julia

Holmes, Jarrod P.

Bhattacharya, Saveri

Lukas, Jason Jerome

Tan-Chiu, Elizabeth

Peoples, George Earl

Sunkari, Vivekananda

Lacher, Markus

Wiseman, Charles L.

机构：

[1] BriaCell Therapeut Corp, Berkeley, CA USA

[2] Wichita NCORP, Wichita, KS USA

[3] Mem Canc Inst, Hollywood, FL USA

[4] Redwood Reg Medcl Grp, Santa Rosa, CA USA

[5] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Florida Canc Specialists & Res Inst, Parkland, FL USA

[8] Canc Vaccine Dev Program, San Antonio, TX USA

[9] BriaCell Therapeut, Berkeley, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3033

引用

页数：2